These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8609521)

  • 1. Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
    Mase G; Zorzon M; Biasutti E; Vitrani B; Cazzato G; Urban F; Frezza M
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348-9. PubMed ID: 8609521
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of myasthenia gravis during interferon-alpha treatment.
    Uyama E; Fujiki N; Uchino M
    J Neurol Sci; 1996 Dec; 144(1-2):221-2. PubMed ID: 8994129
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
    Piccolo G; Franciotta D; Versino M; Alfonsi E; Lombardi M; Poma G
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348. PubMed ID: 8609520
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis during interferon alfa therapy.
    Batocchi AP; Evoli A; Servidei S; Palmisani MT; Apollo F; Tonali P
    Neurology; 1995 Feb; 45(2):382-3. PubMed ID: 7854543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myasthenia during interferon alpha therapy].
    Quilichini R; Mazzerbo F; Baume D; Amiel O; Lafeuillade A; Pellegrino P
    Presse Med; 1995 Sep 2-9; 24(25):1178. PubMed ID: 7567837
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegylated interferon induced myasthenia crisis--a case report.
    Congeni JP; Kirkpatrick RB
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):123-5. PubMed ID: 23492465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].
    Konishi T
    Rinsho Shinkeigaku; 1996 Aug; 36(8):980-5. PubMed ID: 8958752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis following IFN-alpha-2a treatment.
    Bora I; Karli N; Bakar M; Zarifoğlu M; Turan F; Oğul E
    Eur Neurol; 1997; 38(1):68. PubMed ID: 9252802
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C.
    Arai H; Tanaka M; Ohta K; Kojo T; Niijima K; Imawari M
    Lancet; 1995 Mar; 345(8949):582. PubMed ID: 7677847
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.
    Oishi A; Miyamoto K; Kashii S; Yoshimura N
    Br J Ophthalmol; 2005 Nov; 89(11):1542-3. PubMed ID: 16234478
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
    Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose interferon-alpha is safe in patients with myasthenia gravis.
    Bolay H; Karabudak R; Varli K; Saribas O
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):302-3. PubMed ID: 9069506
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of myasthenia gravis after interferon alpha therapy.
    Gurtubay IG; Morales G; Aréchaga O; Gállego J
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):75-8. PubMed ID: 10207675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis exacerbation induced by interferon-alpha. Report of two cases.
    Pauluzzi P; Kokelj F; Perkan V; Pozzato G; Moretti M
    Acta Derm Venereol; 1993 Oct; 73(5):395. PubMed ID: 7904414
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis induced by alpha-interferon therapy.
    Pérez A; Perella M; Pastor E; Cano M; Escudero J
    Am J Hematol; 1995 Aug; 49(4):365-6. PubMed ID: 7639296
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid function and interferon treatment in chronic hepatitis C.
    Picciotto A; Varagona G; Cianciosi P; Franceschini R; Garibaldi A; Celle G
    Gut; 1993 Apr; 34(4):574. PubMed ID: 8338570
    [No Abstract]   [Full Text] [Related]  

  • 18. Untreated hepatitis C may provoke myasthenia gravis.
    Reading PJ; Newman PK
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):820. PubMed ID: 9647325
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis after interferon-alpha treatment.
    Lensch E; Faust J; Nix WA; Wandel E
    Muscle Nerve; 1996 Jul; 19(7):927-8. PubMed ID: 8965856
    [No Abstract]   [Full Text] [Related]  

  • 20. Peginterferon and ribavirin for hepatitis C.
    Evoli A; Servidei S
    N Engl J Med; 2007 Mar; 356(12):1269-70; author reply 1271. PubMed ID: 17380575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.